Cargando…

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines

PURPOSE: This study was conducted to investigate antibody immune responses induced by BNT162b2 and AZD1222 human COVID-19 vaccines in Riyadh city, Saudi Arabia. PATIENTS AND METHODS: ELISA was used to evaluate antibodies, against the SARS-CoV-2 spike S1 protein, in serum samples from 432 vaccinated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alharbi, Naif Khalaf, Al-Tawfiq, Jaffar A, Alwehaibe, Amal, Alenazi, Mohamed W, Almasoud, Abdulrahman, Algaisi, Abdullah, Alhumaydhi, Fahad A, Hashem, Anwar M, Bosaeed, Mohammed, Alsagaby, Suliman A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348632/ https://www.ncbi.nlm.nih.gov/pubmed/35937784 http://dx.doi.org/10.2147/IDR.S362848

Ejemplares similares

Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019
por: Aljasim, Taibah A., et al.
Publicado: (2020)

Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020
por: Alenazi, Mohammed W., et al.
Publicado: (2022)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2019)

Haematological and radiological-based prognostic markers of COVID-19
por: Alsagaby, Suliman A., et al.
Publicado: (2021)

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera
por: Almasaud, Abdulrahman, et al.
Publicado: (2019)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients
por: Alyabsi, Mesnad, et al.
Publicado: (2022)

Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers
por: Alharbi, Suliman A, et al.
Publicado: (2020)

Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells
por: Alsagaby, Suliman A, et al.
Publicado: (2020)

Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate
por: Hala, Sharif, et al.
Publicado: (2021)

Development and Evaluation of Enzyme-Linked Viral Immune Capture Assay for Detection of SARS-CoV-2
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

A combined model for COVID-19 pandemic control: The application of Haddon's matrix and community risk reduction tools combined
por: Khan, Anas, et al.
Publicado: (2022)

Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
por: Algaissi, Abdullah A., et al.
Publicado: (2020)

Cancer in Saudi Arabia (CSA): Web-Based Application to Study Cancer Data Among Saudis Using Waterfall Model
por: Alsagaby, Suliman A, et al.
Publicado: (2021)

Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
por: Alharbi, Naif Khalaf, et al.
Publicado: (2021)

COVID-19 reinfection: A multicenter retrospective study in Saudi Arabia
por: Shaheen, Naila A., et al.
Publicado: (2022)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Mechanistic Insight into the Binding of Huperzine a with Human Transferrin: Computational, Spectroscopic and Calorimetric Approaches
por: Atiya, Akhtar, et al.
Publicado: (2022)

Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia
por: Alqahtani, Saeed Mohammed, et al.
Publicado: (2021)

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
por: Degnah, Afnan A., et al.
Publicado: (2020)

Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome
por: Saib, Israa, et al.
Publicado: (2021)

Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches
por: Shamsi, Anas, et al.
Publicado: (2022)

Elucidating the Interactions of Fluoxetine with Human Transferrin Employing Spectroscopic, Calorimetric, and In Silico Approaches: Implications of a Potent Alzheimer’s Drug
por: Khan, Mohd Shahnawaz, et al.
Publicado: (2022)

Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics
por: Anjum, Farah, et al.
Publicado: (2022)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity
por: AlKhalifah, Joud Mohammed, et al.
Publicado: (2023)

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
por: Wang, Gang, et al.
Publicado: (2022)

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
por: Bosaeed, Mohammad, et al.
Publicado: (2022)

Viruses Causing Aseptic Meningitis: A Tertiary Medical Center Experience With a Multiplex PCR Assay
por: Aldriweesh, Mohammed A., et al.
Publicado: (2020)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
por: Serwanga, Jennifer, et al.
Publicado: (2023)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
por: Yang, Chunmin, et al.
Publicado: (2022)

Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness
por: Alsagaby, Suliman A.
Publicado: (2019)

Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia
por: Alsagaby, Suliman A.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_935esdsbcpssuii8vo337jsq7q